Spots Global Cancer Trial Database for Eribulin in mTNBC Patients
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Eribulin in mTNBC Patients
Official Title: An Observational, Retrospective Study of Eribulin in Advanced Breast Cancer
Study ID: NCT04541420
Conditions
Interventions
Study Description
Brief Summary: To evaluate the efficacy and safety of Eribulin in patients with advanced breast cancer.
Detailed Description:
Eligibility
Minimum Age:
Eligible Ages: CHILD, ADULT, OLDER_ADULT
Sex: FEMALE
Healthy Volunteers: No
Locations
Fudan University Shanghai Cancer Center, Shanghai, Shanghai, China
Contact Details
Name: Biyun Wang, Professor
Affiliation: Fudan University
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
